Debt-to-equity of AXIM BIOTECHNOLOGIES, INC. from 30 Jun 2012 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
AXIM BIOTECHNOLOGIES, INC. quarterly Debt-to-equity in % history and change rate from 30 Jun 2012 to 30 Jun 2024.
  • AXIM BIOTECHNOLOGIES, INC. Debt-to-equity for the quarter ending 30 Jun 2024 was -152%, a 9.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 -152% +16% +9.5% 30 Jun 2024
Q1 2024 -153% +37% +20% 31 Mar 2024
Q4 2023 -156% +56% +26% 31 Dec 2023
Q3 2023 -162% +78% +32% 30 Sep 2023
Q2 2023 -168% +534% +76% 30 Jun 2023
Q1 2023 -190% +45580% +100% 31 Mar 2023
Q4 2022 -212% -940% -129% 31 Dec 2022
Q3 2022 -240% -671% -156% 30 Sep 2022
Q2 2022 -702% -1293% -219% 30 Jun 2022
Q1 2022 -45770% -46376% -7647% 31 Mar 2022
Q4 2021 728% -184% -20% 31 Dec 2021
Q3 2021 431% +1465% 30 Sep 2021
Q2 2021 591% 30 Jun 2021
Q1 2021 606% 31 Mar 2021
Q4 2020 912% 31 Dec 2020
Q3 2020 -1034% 30 Sep 2020
Q1 2017 -135% +128% +49% 31 Mar 2017
Q4 2016 -135% 31 Dec 2016
Q3 2016 -135% 30 Sep 2016
Q2 2016 -154% 30 Jun 2016
Q1 2016 -263% 31 Mar 2016
Q3 2012 593% 30 Sep 2012
Q2 2012 525% 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.